mild cognitive impairment and alzheimer’s

Mild cognitive impairment is when the expected cognitive decline of normal aging has rapidly progressed to the more serious decline of dementia.

It involves problems with memory, language, cognition and difficulty with social abilities and daily functioning. Alzheimer’s is the most common type of dementia.

Alzheimer's disease, also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and gradually worsens over time.

It is the cause of 60–70% of cases of dementia. The most common symptom is difficulty in remembering recent events that can evolve into problems with language, disorientation, mood swings.

Cognitive impairment and dementia affect the brain in many different areas. Hyperbaric Oxygen Therapy has recently been studied in several double blind trials and has been found to be an effective therapy for neurological disorders.

The research also suggests HBOT is effective in the management of some metabolic disorders such as type 2 diabetes which can play a part in dementia and Alzheimer’s.

While HBOT is not a cure for Alzheimer’s, it has been reported to be beneficial in slowing the progression of the disease and bringing about generalized improvement in cognition and function.

Patients in our clinic have reported less anxiety, a sense of well-being, improved memory, regaining conversational ability, less confusion, better cognition, and less depression.

References:

• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352566/

• https://www.sciencedaily.com/releases/2019/01/190124124742.htm

• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795254/